<?xml version="1.0" encoding="UTF-8"?>
<p>Starch as biopolymer is often used in pharmaceutical formulations due to its biodegradability and versatility [
 <xref rid="B126-pharmaceutics-13-00631" ref-type="bibr">126</xref>,
 <xref rid="B127-pharmaceutics-13-00631" ref-type="bibr">127</xref>]. Modified starch had been also investigated for encapsulation of EOs in various forms, for example, spherical aggregates, nanoparticles, or porous compounds [
 <xref rid="B128-pharmaceutics-13-00631" ref-type="bibr">128</xref>,
 <xref rid="B129-pharmaceutics-13-00631" ref-type="bibr">129</xref>,
 <xref rid="B130-pharmaceutics-13-00631" ref-type="bibr">130</xref>,
 <xref rid="B131-pharmaceutics-13-00631" ref-type="bibr">131</xref>]. In a recent investigation, the nanoencapsulation of clove essential oil in 3D nano-network porous starch-based material to enhance the antimicrobial activities of the matrix, it was pursued [
 <xref rid="B132-pharmaceutics-13-00631" ref-type="bibr">132</xref>]. The study presented an elaborate preparation process that included starch gelatinization with subsequent complexation (and further remove) of the CaCO
 <sub>3</sub> template with 3D-nanoparticles formation for the clove EO encapsulation. The new nanoparticles containing EO presented enhanced and prolonged bacteriostatic effect. The schematic illustrative preparation of the nanoparticles was presented by the authors (
 <xref ref-type="fig" rid="pharmaceutics-13-00631-f004">Figure 4</xref>).
</p>
